Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history

» Details

Guru Trades

Q3 2015

VEU Guru Trades in Q3 2015

First Eagle Investment 73,800 sh (unchged)
» More
Q4 2015

VEU Guru Trades in Q4 2015

First Eagle Investment 9,800 sh (-86.72%)
» More
Q1 2016

VEU Guru Trades in Q1 2016

First Eagle Investment 9,800 sh (unchged)
» More
Q2 2016

VEU Guru Trades in Q2 2016

First Eagle Investment Sold Out
» More

Ratios

vs
industry
vs
history
P/E(ttm) 15.40
VEU's P/E(ttm) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. VEU: 15.40 )
Ranked among companies with meaningful P/E(ttm) only.
VEU' s P/E(ttm) Range Over the Past 10 Years
Min: 0  Med: 0 Max: 15.4
Current: 15.4
0
15.4
PE(NRI) 15.40
VEU's PE(NRI) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. VEU: 15.40 )
Ranked among companies with meaningful PE(NRI) only.
VEU' s PE(NRI) Range Over the Past 10 Years
Min: 0  Med: 0 Max: 15.4
Current: 15.4
0
15.4
P/B 1.54
VEU's P/B is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. VEU: 1.54 )
Ranked among companies with meaningful P/B only.
VEU' s P/B Range Over the Past 10 Years
Min: 0  Med: 0 Max: 1.54
Current: 1.54
0
1.54

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 2.76
VEU's Dividend Yield is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. VEU: 2.76 )
Ranked among companies with meaningful Dividend Yield only.
VEU' s Dividend Yield Range Over the Past 10 Years
Min: 0  Med: 0 Max: 2.76
Current: 2.76
0
2.76
Yield on cost (5-Year) 2.76
VEU's Yield on cost (5-Year) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. VEU: 2.76 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
VEU' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0  Med: 0 Max: 2.76
Current: 2.76
0
2.76

More Statistics

Short Percentage of Float0.00%
52-Week Range $38.18 - 46.01
Shares Outstanding (Mil)99,999,999.99
» More Articles for VEU

Headlines

Articles On GuruFocus.com
VR Is not a Toy, it Is a Tool Aug 29 2016 
August Buffett-Munger Bargain Newsletter is Ready for Download Aug 29 2016 
What the iPhone 7 Does Not Mean for Apple Aug 29 2016 
Ford Europe Success Masked by Trouble on US Shores Aug 29 2016 
Innovation, Not Sales Growth, Is Procter & Gamble’s Challenge Aug 29 2016 
Choose How Many Stocks You Will Own Aug 29 2016 
Will the Checkbook Survive Online Payments? Aug 29 2016 
Why Under Armour Can Still Move Higher Aug 29 2016 
GNC is a Joel Greenblatt Bargain Walking a Tight Rope Aug 29 2016 
Healthcare Winners: Stryker Corp., UnitedHealth Group Inc. Aug 29 2016 

More From Other Websites
Has the Short Interest in Marathon Petroleum Fallen? Aug 30 2016
Is It Time to Invest in International Funds? Aug 29 2016
Despite Litigation, Teva’s Copaxone Could See Robust 2016 Revenue Aug 24 2016
Performance of AstraZeneca’s Growth Platforms in 2Q16 Aug 23 2016
Why Did Novo’s Valuation Multiple Fall Recently? Aug 22 2016
How Did Novo’s Diabetes and Obesity Care Segment Perform in 1H16? Aug 22 2016
Bill Gross’s Views on Growth and Inflation Aug 22 2016
Teva Pharmaceutical’s 2016 Valuation Compared to Peers Aug 19 2016
How the Student Debt Crisis Resembles the Sub-Prime Crisis Aug 18 2016
Analysts’ Recommendations for PBR: A Mixed Bag Aug 17 2016
Fund managers remain defensive into the ongoing rally Aug 16 2016
How Did Valeant’s Segments Perform in 2Q16? Aug 12 2016
Contraction in China’s July Manufacturing PMI Aug 08 2016
How Brexit Could Impact GDP, Capital Flows, and Growth in the UK Aug 05 2016
Can Valeant’s Margins for 2Q16 Meet Expectations? Aug 05 2016
How Has Eni’s Implied Volatility Trended after Its Latest Earnings? Aug 04 2016
Why Flash US Services PMI Remained Subdued in July Aug 04 2016
Is BoJ’s Continuous Stimulus Expansion Helping Japan’s Economy? Aug 04 2016
What to Expect from Valeant’s Upcoming Q216 Earnings Aug 03 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK